Breast cancer is the most common cancer and the leading cause of cancer-related death among women. Research has demonstrated that MUC1-derived tumor markers, cancer antigen 27-29 (CA27-29), showed to be of prognostic value in metastatic breast cancer and were routinely used in the management of patients at this stage. With advanced and high-end technologies, rich experienced scientists, Creative Biolabs is an excellent service provider in the field of tumor marker assay. After long years ahead to fully comprehend tumor markers, we launch our CA27-29 assay portfolio service which can be used in targeted cancer therapy and diagnosis. Next, we will introduce the assay portfolio service about CA27-29 targeting as follows.
CA27-29, also known as breast carcinoma-associated antigen, is a carbohydrate-containing protein antigen produced by the MUC-1 gene. MUC-1 is the product of the MUC-1 gene, which is a transmembrane glycoprotein expressed by glandular epithelia. The function of MUC-1 is associated with cell signaling and anti-pathogens. Additionally, MUC-1 was expressed in a variety of malignant cells including ovarian, lung, pancreatic, breast, and prostate carcinomas.
Fig.1 Model of MUC1 role in the tumor microenvironment. (Cascio, 2016)
The expression of CA27-29 is widely exhibited in various other malignancies and other benign disorders related to liver, breast, kidney, and in patients with ovarian cysts. Especially, CA27-29 is highly related to breast cancer. Research showed that about 80% of women with breast cancer have an increased CA27-29 level, as increased in 30% of patients with the low-stage disease, and 60 to 70% of patients with advanced-stage breast cancer. CA27.29 is derived from MUC-1 and can be applied with other assessments to monitor treatment in metastatic breast cancer. Studies have demonstrated that CA27.29 tends to be more specific and sensitive than CA15-3 which is also derived from MUC-1. The test of CA27.29 marker is applied to monitor the progression and metastatic state of breast cancer.
If you are interested in our service, please contact us or directly send us.
For Research Use Only | Not For Clinical Use